Charlotte Graafland, the Netherlands

Clinical (1)
PB2.4: Onset-predictive biomarker testing for clinical trial recruitment in FTD: perspectives of (potential) mutation carriers
Date: 20 Sep 2024Time: 09:42 - 09:45 CET

Home › Charlotte Graafland, the Netherlands